Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer

Breast Cancer Research and Treatment

Volumn 117, Issue 1, 2009, Pages 205-210

  Zauderer, Marjorie ^a   Patil, Sujata ^b   Hurria, Arti ^c  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Breast Cancer; Dose Dense Chemotherapy; Older Patient

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ERYTHROPOIETIN; HEMOGLOBIN; PACLITAXEL;

ADJUVANT THERAPY; ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; BRAIN ISCHEMIA; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; COMORBIDITY; CONFUSION; CONGESTIVE HEART FAILURE; CONNECTIVE TISSUE DISEASE; CONSULTATION; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DIARRHEA; DIZZINESS; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPHAGIA; DYSPNEA; EMBOLISM; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; FRACTURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMIPLEGIA; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOKALEMIA; HYPONATREMIA; INFECTION; LEUKEMIA; LEUKOPENIA; LIVER DISEASE; LUNG EMBOLISM; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; MYOPATHY; NAUSEA; NEUTROPENIA; PAIN; PERIPHERAL VASCULAR DISEASE; PNEUMONIA; PRIORITY JOURNAL; SENSORY NEUROPATHY; SIDE EFFECT; SINUS TACHYCARDIA; SYNCOPE; THORAX PAIN; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT OUTCOME; ULCER;

AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMORBIDITY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES;

EID: 69049093248     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0116-0     Document Type: Article

References (19)

1. A Jemal R Siegel E Ward T Murray J Xu MJ Thun 2007 Cancer statistics, 2007 CA Cancer J Clin 57 1 43 66
2. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, Mariotto A, Miller BA, Feuer EJ, Altekruse SF, Lewis DR, Clegg L, Eisner MP, Reichman M, Edwards BK (eds). SEER Cancer Statistics Review, 1975-2005. National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975-2005/, based on November 2007 SEER data submission, posted to the SEER web site, 2008
3. LF Hutchins JM Unger JJ Crowley CA Coltman Jr KS Albain 1999 Underrepresentation of patients 65 years of age or older in cancer- treatment trials N Engl J Med 341 27 2061 2067 10.1056/NEJM199912303412706
4. HB Muss S Woolf D Berry et al. 2005 Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer JAMA 293 9 1073 1081 10.1001/jama.293.9.1073
5. ML Citron DA Berry C Cirrincione et al. 2003 Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 J Clin Oncol 21 8 1431 1439 10.1200/JCO.2003.09.081
6. ME Charlson P Pompei KL Ales CR MacKenzie 1987 A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 5 373 383 10.1016/0021-9681(87)90171-8
7. Early Beast Cancer Trialists' Collaborative Group 2005 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 9472 1687 1717 10.1016/S0140-6736(05)66544-0
8. R Yancik MN Wesley LA Ries RJ Havlik BK Edwards JW Yates 2001 Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older JAMA 285 7 885 892 10.1001/jama.285.7.885
9. WA Satariano DR Ragland 1994 The effect of comorbidity on 3-year survival of women with primary breast cancer Ann Intern Med 120 2 104 110
10. G Frasci V Lorusso N Panza et al. 2000 Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer J Clin Oncol 18 13 2529 2536
11. X Du JS Goodwin 2001 Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data J Clin Oncol 19 5 1455 1461
12. EB Elkin A Hurria N Mitra D Schrag KS Panageas 2006 Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort J Clin Oncol 24 18 2757 2764 10.1200/JCO.2005.03.6053
13. EC Dees S O'Reilly SN Goodman et al. 2000 A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer Cancer Invest 18 6 521 529 10.3109/07357900009012191
14. DB Reuben LV Rubenstein SH Hirsch RD Hays 1992 Value of functional status as a predictor of mortality: results of a prospective study Am J Med 93 6 663 669 10.1016/0002-9343(92)90200-U
15. M Extermann J Overcash GH Lyman J Parr L Balducci 1998 Comorbidity and functional status are independent in older cancer patients J Clin Oncol 16 4 1582 1587
16. JM Eagles JA Beattie DB Restall F Rawlinson S Hagen GW Ashcroft 1990 Relation between cognitive impairment and early death in the elderly BMJ 300 6719 239 240
17. C Wolfson DB Wolfson M Asgharian et al. 2001 A reevaluation of the duration of survival after the onset of dementia N Engl J Med 344 15 1111 1116 10.1056/NEJM200104123441501
18. TE Seeman GA Kaplan L Knudsen R Cohen J Guralnik 1987 Social network ties and mortality among the elderly in the Alameda County Study Am J Epidemiol 126 4 714 723
19. BW Penninx JM Guralnik L Ferrucci EM Simonsick DJ Deeg RB Wallace 1998 Depressive symptoms and physical decline in community-dwelling older persons JAMA 279 21 1720 1726 10.1001/jama.279.21.1720